Genetic disorders market research report, Genetic disorders treatment market - Ken Research

1
Genetic disorders market is forecast to grow at
13.6 CAGR Ken Research
2
Genetic disorders market is forecast to grow from
19.6 billion in 2016 to 47.7 billion in 2023,
at a CAGR of 13.6. This high level of growth
will be driven largely by orphan drugs for the
treatment of rare genetic disorders. Report
titled Global Genetic Disorders Drugs Market to
2023 - A Rapidly Growing Treatment Landscape
Driven by Targeted Complement System Inhibitors
and Enzyme Replacement Therapies to Treat PNH and
Lysosomal Storage Disease helps the reader to
gain more insights in the area of genetic
disorders covering aspects such as Symptoms,
Diagnosis, Treatment, Key products, clinical
trials, company analysis and future forecast. As
rare genetic disorders are often debilitating or
fatal, with low prevalence, sponsors are willing
to pay for some of the most expensive treatments
in the pharmaceutical industry. This contributes
to high sales revenue, despite small patient
groups. Orphan drugs are able to generate high
revenue because of developmental incentives such
as marketing exclusivity, which allows for longer
periods before generics and biosimilars can enter
the market. Furthermore, other incentives such as
tax credits and accelerated approval lower the
developmental costs faced by pharmaceutical
companies, reducing the inherent financial risks
involved and increasing the likelihood of
recouping developmental costs from product sales.
3
The genetic disorders market has a strong
presence of specialized companies that focus on
the development of treatments for genetic
disorders, including Alexion, Sanofi, Shire and
Vertex. Treating genetic disorders can be a
desirable prospect, as many genetic disorders are
underserved with only symptomatic treatments
allowing for high prices. Furthermore, a range of
lucrative incentives such as orphan drug status
are available for pharmaceutical companies to
develop treatments for rare diseases, including
extended periods of market exclusivity and tax
credits. There is evidence of more companies
moving into this therapy area, and a resultant
diversification of market share. Key Topics
Covered in the Report Genetic disorders market
research report Genetic disorders treatment
market Genetic disorders medicine market Genetic
disorder cases worldwide Genetic disorder Drugs
Market G Protein-Coupled Receptor Modulators
Market Metabolic Enzyme Mediators Market Key
Pipeline Products in Genetic Disorders Market
4
Clinical Trials in Genetic disorder Drugs
Market Soliris (eculizumab) Alexion
Market Orkambi (lumacaftor/ivacaftor) Vertex
Market Pulmozyme (dornase alfa) Roche
Market Duchenne Muscular Dystrophy Treatment
Market Lysosomal Storage Disease Treatment
Market Paroxysmal Nocturnal Hemoglobinuria
Treatment Market   To know more about the
publication, click on the link below https//www.
kenresearch.com/contact-us.php   Similar
Reports https//www.kenresearch.com/healthcare/ph
armaceuticals/menstrual-disorders-global-clinical-
trials-review/143032-91.html   https//www.kenrese
arch.com/healthcare/general-healthcare/obsessive-c
ompulsive-disorder-pipeline-review/142731-91.html
5
Contact Us Ken Research Ankur Gupta, Head
Marketing Communications sales_at_kenresearch.com 0
124-4230204